Advisory Committee on Childhood Lead Poisoning Prevention (ACCLPP): Meeting, 1252 [05-271]

Download as PDF 1252 Federal Register / Vol. 70, No. 4 / Thursday, January 6, 2005 / Notices Environmental protection, Pesticides and pest. Dated: December 23, 2004. Jack E. Housenger, Acting Director, Antimicrobials Division, Office of Pesticide Programs. [FR Doc. 05–260 Filed 1–5–05; 8:45 am] BILLING CODE 6560–50–S Internal personnel rules and procedures or matters affecting a particular employee. FOR FURTHER INFORMATION CONTACT: Mr. Robert Biersack, Press Officer, Telephone: (202) 694–1220. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Darlene Harris, Deputy Secretary of the Commission. [FR Doc. 05–377 Filed 1–4–05; 2:33 pm] List of Subjects Dated: December 30, 2004. B. Kathy Skipper, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–271 Filed 1–5–05; 8:45 am] BILLING CODE 6715–01–M FEDERAL COMMUNICATIONS COMMISSION DEPARTMENT OF HEALTH AND HUMAN SERVICES [Report No. 2684] Petitions for Reconsideration and Clarification of Action in Rulemaking Proceeding December 1, 2004. Petitions for Reconsideration and Clarification have been filed in the Commission’s Rulemaking proceeding listed in this Public Notice and published pursuant to 47 CFR Section 1.429(e). The full text of this document is available for viewing and copying in Room CY–B402, 445 12th Street, SW., Washington, DC or may be purchased from the Commission’s copy contractor, Best Copy and Printing, Inc. (BCPI) (1– 800–378–3160). Oppositions to these petitions must be filed by January 21, 2005. See Section 1.4(b)(1) of the Commission’s rules (47 CFR 1.4(b)(1)). Replies to an opposition must be filed within 10 days after the time for filing oppositions have expired. Subject: In the Matter of Second Periodic Review of the Commission’s Rules and Policies Affecting the Conversion to Digital Television (MB Docket No. 03–15). Number of Petitions Filed: 11. Marlene H. Dortch, Secretary. [FR Doc. 05–259 Filed 1–5–05; 8:45 am] BILLING CODE 6712–01–M FEDERAL ELECTION COMMISSION Sunshine Act Notices Tuesday, January 11, 2005 at 10 a.m. PLACE: 999 E Street, NW., Washington, DC. STATUS: This meeting will be closed to the public. Compliance matters pursuant to 2 U.S.C. § 437g. Audits conducted pursuant to 2 U.S.C. § 437g, § 438(b), and Title 26, U.S.C. Matters concerning participation in civil actions or proceedings or arbitration. DATE AND TIME: VerDate jul<14>2003 15:45 Jan 05, 2005 Jkt 205001 BILLING CODE 4163–18–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Advisory Committee on Childhood Lead Poisoning Prevention (ACCLPP): Meeting Centers for Disease Control and Prevention In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the National Center for Environmental Health (NCEH) of the Centers for Disease Control and Prevention (CDC) announces the following committee meeting. Name: Advisory Committee on Childhood Lead Poisoning Prevention. Times and Dates: 8:30 a.m.–5 p.m., March 22, 2005; 8:30 a.m.–12:30 p.m., March 23, 2005. Place: Sheraton New Orleans Hotel, 500 Canal Street, New Orleans, LA 70130, Telephone: (504) 595–6211 or toll free 1– 888–627–7033. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 75 people. Purpose: The Committee provides advice and guidance to the Secretary; the Assistant Secretary for Health; and the Director, CDC, regarding new scientific knowledge and technological developments and their practical implications for childhood lead poisoning prevention efforts. The committee also reviews and reports regularly on childhood lead poisoning prevention practices and recommends improvements in national childhood lead poisoning prevention efforts. Matters To Be Discussed: Update on the Lead and Pregnancy Workgroup Agenda activities, ACCLPP process for work group projects, updates of the clinical and public health implications of adverse health effects of blood lead levels less than 10 µg/dL. Agenda items are subject to change as priorities dictate. Opportunities will be provided during the meeting for oral comments. Depending on the time available and the number of requests, it may be necessary to limit the time of each presenter. For Further Information Contact: Crystal M. Gresham, Program Analyst, Lead Poisoning Prevention Branch, Division of Emergency and Environmental Health Services, NCEH, CDC, 4770 Buford Hwy, NE., M/S F–40, Atlanta, Georgia 30341, telephone (770) 488–7490, fax (770) 488–3635. PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 Publication of closed meeting summary of the Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH). ACTION: Committee Purpose: This board is charged with (a) providing advice to the Secretary, HHS on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS on the scientific validity and quality of dose reconstruction efforts performed for this Program; and (c) upon request by the Secretary, HHS, advise the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Background: The Advisory Board on Radiation and Worker Health met on December 13, 2004, in closed session to discuss Individual Case Dose Reconstruction Reviews. The discussion involved individual dose reconstruction case reviews. The individual cases the ABRWH discussed included personal information of a confidential nature where disclosure would constitute a clearly unwarranted invasion of personal privacy and, therefore, could not be disclosed. A Determination to Close the meeting was approved and published, as required by the Federal Advisory Committee Act. Summary of the Meeting: Attendance was as follows: Board Members: Paul L. Ziemer, Ph.D., Chair. Lew Wade, Ph.D., Executive Secretary (Pro Tem). Antonio Andrade, Ph.D., Member. Roy L. DeHart, M.D., M.P.H., Member. E:\FR\FM\06JAN1.SGM 06JAN1

Agencies

[Federal Register Volume 70, Number 4 (Thursday, January 6, 2005)]
[Notices]
[Page 1252]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-271]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Childhood Lead Poisoning Prevention 
(ACCLPP): Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the National Center for Environmental 
Health (NCEH) of the Centers for Disease Control and Prevention (CDC) 
announces the following committee meeting.

    Name: Advisory Committee on Childhood Lead Poisoning Prevention.
    Times and Dates: 8:30 a.m.-5 p.m., March 22, 2005; 8:30 a.m.-
12:30 p.m., March 23, 2005.
    Place: Sheraton New Orleans Hotel, 500 Canal Street, New 
Orleans, LA 70130, Telephone: (504) 595-6211 or toll free 1-888-627-
7033.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 75 people.
    Purpose: The Committee provides advice and guidance to the 
Secretary; the Assistant Secretary for Health; and the Director, 
CDC, regarding new scientific knowledge and technological 
developments and their practical implications for childhood lead 
poisoning prevention efforts. The committee also reviews and reports 
regularly on childhood lead poisoning prevention practices and 
recommends improvements in national childhood lead poisoning 
prevention efforts.
    Matters To Be Discussed: Update on the Lead and Pregnancy 
Workgroup Agenda activities, ACCLPP process for work group projects, 
updates of the clinical and public health implications of adverse 
health effects of blood lead levels less than 10 [mu]g/dL.
    Agenda items are subject to change as priorities dictate.
    Opportunities will be provided during the meeting for oral 
comments. Depending on the time available and the number of 
requests, it may be necessary to limit the time of each presenter.
    For Further Information Contact: Crystal M. Gresham, Program 
Analyst, Lead Poisoning Prevention Branch, Division of Emergency and 
Environmental Health Services, NCEH, CDC, 4770 Buford Hwy, NE., M/S 
F-40, Atlanta, Georgia 30341, telephone (770) 488-7490, fax (770) 
488-3635.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: December 30, 2004.
B. Kathy Skipper,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 05-271 Filed 1-5-05; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.